"Learn how you can get comprehensive cancer care services under one roof in a patient-centered environment at Avera Cancer Institute in Sioux Falls, SD."

During the past decade, Avera Cancer Institute conducted 143 clinical trials. In the 10-year time frame, 143 clinical trials started and 162 clinical trials were completed, i.e. on average, 113.3% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 68 clinical trials were completed. i.e. 106.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Avera Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 97 trials, followed by "Alliance for Clinical Trials in Oncology" with 69 trials sponsored, "SWOG Cancer Research Network" with 25 trials sponsored, "Eastern Cooperative Oncology Group" with 23 trials sponsored and "Children's Oncology Group" with 23 trials sponsored. Other sponsors include 140 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avera Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 199 trials as a collaborator, "NRG Oncology" with 32 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator and "SWOG Cancer Research Network" with 10 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Avera Cancer Institute" are "Breast Cancer" (40 trials), "Lung Cancer" (17 trials), "Leukemia" (14 trials), "Colorectal Cancer" (13 trials) and "Lymphoma" (13 trials). Many other conditions were trialed in "Avera Cancer Institute" in a lesser frequency.

Most popular intervention types in "Avera Cancer Institute" are "Drug" (316 trials), "Other" (155 trials), "Biological" (126 trials), "Procedure" (69 trials) and "Radiation" (59 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (54 trials), "Paclitaxel" (33 trials), "Questionnaire Administration" (30 trials) and "placebo" (27 trials). Other intervention names were less common.

The vast majority of trials in "Avera Cancer Institute" are 299 trials for "All" genders, 75 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Avera Cancer Institute". undefined are not yet recruiting, 57 are recruiting, 107 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 185 completed trials in Avera Cancer Institute, 3 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Avera Cancer Institute, 23 "Phase 1" clinical trials were conducted, 171 "Phase 2" clinical trials and 183 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".